Renhe Pharmacy Co., Ltd. (000650.SZ)
CNY 5.93
(-0.17%)
CNY 5.93
(-0.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 577.44 Million | 1.26 Billion | 777.71 Million | 871.13 Million | 693.97 Million | 569.45 Million |
| Net Income | 567.25 Million | 711.55 Million | 799.87 Million | 657.65 Million | 619.3 Million | 584.08 Million |
| Depreciation & Amortization | 147.14 Million | 117.15 Million | 86.63 Million | 83.85 Million | 96.25 Million | 91.81 Million |
| Deferred income taxes | -9.18 Million | -10.81 Million | -759.57 Thousand | 1.09 Million | -1.29 Million | -2.06 Million |
| Stock-based compensation | - | 17.32 Million | 10.39 Million | -1.09 Million | 1.29 Million | - |
| Change in working capital | -421.64 Million | 410.18 Million | -86.3 Million | 194.54 Million | -34.31 Million | -147.82 Million |
| Other non-cash items | 1 Billion | 24.58 Million | -32.12 Million | -64.92 Million | 12.73 Million | 41.37 Million |
| Investing Cash Flow | -366.26 Million | -575.16 Million | 319.26 Million | -1.2 Billion | -862.93 Million | -23.5 Million |
| Investments in PPE | -186.54 Million | -221.08 Million | -499.78 Million | -218.2 Million | -144.1 Million | -70.12 Million |
| Acquisitions | 7.77 Million | 15.78 Million | -704.64 Million | 188.82 Million | 77.88 Million | 30 Million |
| Investment purchases | -6.23 Billion | -8.03 Billion | -10.84 Billion | -11.92 Billion | -11.83 Billion | -8.77 Billion |
| Sales/Maturities of investments | 6.04 Billion | 7.66 Billion | 12.34 Billion | 10.75 Billion | 11.03 Billion | 8.79 Billion |
| Other Investing Activities | -107.49 Million | 288.13 Thousand | 22.62 Million | 1.11 Million | 143.16 Thousand | -517.18 Thousand |
| Financing Cash Flow | -421.8 Million | -230.07 Million | -462.19 Million | 617.6 Million | -168.01 Million | -141.24 Million |
| Debt repayment | -7.06 Million | -5.54 Million | -60 Million | -60 Million | - | - |
| Dividends payments | -279.98 Million | -139.99 Million | -279.98 Million | -123.83 Million | -123.83 Million | -124.56 Million |
| Common Stock Repurchased | -60.07 Million | - | -199.63 Million | -59.34 Million | - | - |
| Common Stock Issuance | - | - | 139.74 Million | -657.44 Thousand | - | - |
| Other Financing Activities | -74.67 Million | -84.35 Million | -59.08 Million | 907.15 Million | -44.13 Million | -16.67 Million |
| Accounts receivables | -118.15 Million | 127.09 Million | -62.47 Million | 54.15 Million | -107.06 Million | -74.21 Million |
| Accounts payables | -313.27 Million | 182.27 Million | 101.34 Million | 68.87 Million | 99 Million | 9.76 Million |
| Inventory | 9.78 Million | 111.62 Million | -124.41 Million | 69.81 Million | -24.96 Million | -81.3 Million |
| Other working capital | -322.46 Million | -10.81 Million | -759.57 Thousand | 1.7 Million | -1.29 Million | -66.52 Million |
| Cash at beginning of period | 2.82 Billion | 2.36 Billion | 1.72 Billion | 1.41 Billion | 1.75 Billion | 1.35 Billion |
| Cash at end of period | 2.61 Billion | 2.82 Billion | 2.36 Billion | 1.7 Billion | 1.41 Billion | 1.75 Billion |
| Capital Expenditure | -186.54 Million | -221.08 Million | -499.78 Million | -218.2 Million | -144.1 Million | -70.12 Million |
| Effect of forex changes on cash | - | -205.37 | -158.23 | - | 0.96 | - |
| Net cash flow / Change in cash | -210.94 Million | 464.73 Million | 634.78 Million | 288.64 Million | -336.97 Million | 404.7 Million |
| Free Cash Flow | 390.89 Million | 1.04 Billion | 277.93 Million | 652.92 Million | 549.86 Million | 499.33 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 78.5 Million | 159.87 Million | 177.29 Million | 567.25 Million | 26.88 Million | 183.82 Million |
| Depreciation & Amortization | - | 28.57 Million | 28.57 Million | 147.14 Million | 36.99 Million | -70.42 Million |
| Deferred income taxes | - | - | - | -9.18 Million | - | - |
| Stock-based compensation | - | 2.21 Million | - | - | - | - |
| Change in working capital | - | -271.13 Million | - | -421.64 Million | -108.36 Million | 218.45 Million |
| Other non-cash items | -126.82 Million | 122.28 Million | -48.35 Million | 1 Billion | 323.42 Million | -191.2 Million |
| Investing Cash Flow | -162.25 Million | -429.23 Million | -1.61 Billion | -366.26 Million | 1.22 Billion | -183.92 Million |
| Investments in PPE | -60.84 Million | -101.81 Million | -74.97 Million | -186.54 Million | -49.78 Million | -37.03 Million |
| Acquisitions | 822.29 Thousand | 1.26 Million | 8.78 Million | 7.77 Million | 6.52 Million | 1.16 Million |
| Investment purchases | -1.82 Billion | -1.6 Billion | -3.47 Billion | -6.23 Billion | -1.25 Billion | -1.63 Billion |
| Sales/Maturities of investments | 1.72 Billion | 1.27 Billion | 1.92 Billion | 6.04 Billion | 2.52 Billion | 1.49 Billion |
| Other Investing Activities | - | -323.09 Million | -1.52 Billion | -107.49 Million | 1.29 Billion | -749.99 Thousand |
| Financing Cash Flow | -290.26 Million | 70.06 Million | -57.11 Million | -421.8 Million | -141.82 Million | 750 Thousand |
| Debt repayment | - | - | - | -7.06 Million | - | - |
| Dividends payments | - | - | - | -279.98 Million | -569.1 Thousand | - |
| Common Stock Repurchased | 39.93 Million | -39.93 Million | - | -60.07 Million | -60.07 Million | - |
| Common Stock Issuance | -70.06 Million | 70.06 Million | - | - | - | - |
| Other Financing Activities | -260.13 Million | 39.93 Million | -57.11 Million | -74.67 Million | 205.31 Million | 750 Thousand |
| Accounts receivables | - | -312.54 Million | - | -118.15 Million | -118.15 Million | 234.58 Million |
| Accounts payables | - | - | - | -313.27 Million | - | - |
| Inventory | - | 39.19 Million | - | 9.78 Million | 9.78 Million | -16.12 Million |
| Other working capital | - | 2.21 Million | - | - | - | - |
| Cash at beginning of period | 989.49 Million | 1.08 Billion | 2.61 Billion | 2.82 Billion | 1.22 Billion | 1.3 Billion |
| Cash at end of period | 478.64 Million | 989.49 Million | 1.08 Billion | 2.61 Billion | 2.61 Billion | 1.21 Billion |
| Capital Expenditure | -60.84 Million | -101.81 Million | -74.97 Million | -186.54 Million | -49.78 Million | -37.03 Million |
| Effect of forex changes on cash | - | - | - | - | - | -39.86 Million |
| Net cash flow / Change in cash | -510.84 Million | -92.68 Million | -1.53 Billion | -210.94 Million | 1.38 Billion | -82.39 Million |
| Free Cash Flow | -109.17 Million | 151.78 Million | 53.96 Million | 390.89 Million | 263.53 Million | 103.61 Million |
MAFATIND
1330
SOHO
SSII
282330
EZJ